Screener
LB Pharmaceuticals Inc LBRX Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q1 '25 | Q4 '24 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 35.7×— | 41.4×+37.9× | 47.6×— | —— | 3.6×— | |
| Leverage | ||||||
| Debt-to-equity | 0×— | 0×— | 0×— | —— | —— | |
| Per Share | ||||||
| Book value per share | $13.41+105% | $37.45+114% | $53.42+121% | -$276.88— | -$263.95— | |
| Valuation | ||||||
| Market capitalization | $1.2B+247% | $563.16M— | $354.37M— | —— | —— | |
| Price / book | 3.2×+2.1× | 1.9×— | 1.1×— | —— | —— |
FAQ
- Where do LB Pharmaceuticals Inc's ratios come from?
- Every ratio is computed from LB Pharmaceuticals Inc's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.